Sunil Agarwal, Chief Medical Officer at Ultragenyx Pharmaceutical Inc. (RARE), sold 650 shares at $66.00 ($43K) on 2016-05-24, disclosed to the SEC on 2016-05-26.
Scheduled sale ($43k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| RARE | SELL | 2016-07-21 | $34K | — | Filing → |
| RARE | SELL | 2016-06-21 | $35K | — | Filing → |
| RARE | SELL | 2016-04-21 | $46K | — | Filing → |